Training patients for self-administration of a new subcutaneous C1-inhibitor concentrate for hereditary angioedema.
Elyse Murphy, Christine Donahue, Laurel Omert and 4 others
PMID 30534402WHAT IT FOUND
Nurses can train patients with hereditary angioedema to self-inject subcutaneous C1 inhibitor, using step-by-step teaching, competency checks, and close follow-up.
This is expert guidance, not proof the training improves outcomes.
Key findings
01Nurses can train patients with hereditary angioedema to self-administer subcutaneous C1-INH(SC) using individualised teaching and competency checks.
02Training should cover reconstitution, injection site preparation, and injection, including rotating sites and injecting slowly.
03Patients need on-demand treatment for breakthrough attacks and should not use C1-INH(SC) to treat an attack.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The paper reports expert consensus recommendations, not a trial or outcome study of the training programme. The number of nurses on the panel is not stated, so the breadth of experience is unclear. Some authors are employees of CSL Behring, the manufacturer of C1-INH(SC), and CSL Behring was the financial sponsor of the manuscript. Other authors received stipends, travel reimbursements, grants or honoraria from CSL Behring and related companies. COMPACT results summarised here came from other publications and were not the primary aim of this paper.
Declared interests
Some authors are employees of CSL Behring, the manufacturer of C1-INH(SC), and CSL Behring was the financial sponsor of the manuscript. Other authors received stipends, travel reimbursements, grants or honoraria from CSL Behring, Dyax, Biocryst or Shire.
The easy way to misread this
Do not read this as proof that nurse training improves patient outcomes. The paper reports consensus recommendations, not a tested training programme, and it was sponsored by the manufacturer.